INDIVIOR PHARMACEUTICALS INC (INDV) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:INDV • GB00BN4HT335

35.38 USD
+0.67 (+1.93%)
At close: Jan 30, 2026
35.38 USD
0 (0%)
After Hours: 1/30/2026, 8:00:02 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to INDV. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 43.71. This target is 23.56% above the current price.
  • INDV was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about INDV.
  • In the previous month the buy percentage consensus was at a similar level.
  • INDV was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
INDV Historical Analyst RatingsINDV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 35.3836.3642.8443.7152.50 - 2.77% 21.09% 23.56% 48.39%
INDV Current Analyst RatingINDV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2026-01-12 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-31 Piper Sandler Reiterate Overweight -> Overweight
2025-10-30 HC Wainwright & Co. Maintains Buy -> Buy
2025-08-27 Craig-Hallum Maintains Buy -> Buy
2025-08-06 HC Wainwright & Co. Initiate Buy
2025-06-30 Craig-Hallum Maintains Buy -> Buy
2025-03-06 Piper Sandler Maintains Overweight -> Overweight
2024-10-25 Piper Sandler Reiterate Overweight -> Overweight
2024-10-11 Piper Sandler Reiterate Overweight -> Overweight
2024-10-11 Craig-Hallum Maintains Buy -> Buy
2024-09-13 Piper Sandler Reiterate Overweight -> Overweight
2024-07-23 Piper Sandler Initiate Overweight
2024-07-10 Craig-Hallum Maintains Buy -> Buy
2024-04-03 Craig-Hallum Initiate Buy

INDIVIOR PHARMACEUTICALS INC / INDV FAQ

What is the price target for INDV stock?

13 analysts have analysed INDV and the average price target is 43.71 USD. This implies a price increase of 23.56% is expected in the next year compared to the current price of 35.38.


What is the consensus rating for INDV stock?

The consensus rating for INDIVIOR PHARMACEUTICALS INC (INDV) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed INDIVIOR PHARMACEUTICALS INC (INDV)?

The number of analysts covering INDIVIOR PHARMACEUTICALS INC (INDV) is 13.